Chengdu Kanghong Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") announces the following regarding the adjustment of the exercise price of the 2022 stock appreciation rights incentive plan:
- Relevant Approval Procedures
On June 2, 2026, the Company held the 19th meeting of the 8th Board of Directors, which approved the adjustment regarding the exercise price of the 2022 stock appreciation rights incentive plan.
On June 30, 2022, the Company held the 15th meeting of the 7th Board of Directors, which approved the "2022 Stock Appreciation Rights Incentive Plan" and its key points. The Company independently expressed its views on the matter.
On June 30, 2022, the Company held the 12th meeting of the 7th Board of Supervisors, which approved the "2022 Stock Appreciation Rights Incentive Plan" and its key points.
On July 1 to July 10, 2022, the Company conducted a survey regarding the 2022 stock appreciation rights.